Bernafon AG
7
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
14.3%
1 terminated/withdrawn out of 7 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
50%
3 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
A Comparative Clinical Investigation of Musician's Preference With Hearing Aids
Role: lead
A Standard Music Program Compared to an Optimized Music Program
Role: lead
A Comparison of a New Acoustic Feedback Canceller in Hearing Aids With the Current System
Role: lead
A Comparative Clinical Investigation of Two Hearing Instrument Digital Signal Processing
Role: lead
A Clinical Investigation of the Benefit: BTE Hearing Aids Versus ITE Hearing Aids
Role: lead
A Comparative, Controlled, Clinical Investigation and Quality Control of a New Hearing Aid
Role: lead
A Comparison of a Currently Marketed Hearing Aid Programmed With Two Different Fitting Methods
Role: lead
All 7 trials loaded